Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

Market Cap	2.78B
Revenue (ttm)	1.94B
Net Income (ttm)	50.53M
Shares Out	554.67M
EPS (ttm)	0.09
PE Ratio	55.29
Forward PE	n/a
Dividend	0.03 (0.56%)
Ex-Dividend Date	Dec 9, 2024

Volume	16,790,670
Average Volume	13,712,070
Open	5.11
Previous Close	5.15
Day's Range	5.01 - 5.15
52-Week Range	4.03 - 5.87
Beta	0.86
RSI	42.08
Earnings Date	Apr 9, 2025

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, pediatric heat-clearing and cough-relieving oral liquid, pediatric compound chicken gizzard chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharma...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,214
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600222

Financial Performance

In 2024, SHA:600222's revenue was 1.94 billion, a decrease of -6.21% compared to the previous year's 2.07 billion. Earnings were 50.53 million, an increase of 16.00%.